Analysis of Cryopyrin-associated Periodic Syndromes (CAPS) in German Children: Epidemiological, Clinical and Genetic Characteristics
Overview
Affiliations
Background: Cryopyrin-associated periodic syndromes (CAPS) are rare disorders belonging to the group of hereditary periodic fever (HPF)syndromes. These auto-inflammatory diseases(AID) are characterized by recurrent episodes of inflammation with attacks of fever variably associated with serosal, synovial and / or cutaneous inflammation, usually in a self-limiting manner, and with a mostly monogenic origin. The aims were to determine the incidence of CAPS and the spectrum of mutations in the NLRP3 (formerly= CIAS1) gene and to describe the clinical manifestations.
Patients And Methods: A prospective surveillance of children with CAPS was conducted in Germany during a time period of 3 years(2003-2006). Monthly inquiries were sent to 370 children's hospitals by the German Paediatric Surveillance Unit (Clinic-ESPED, n1) and to 2 laboratories (Laboratory-ESPED, n2). Inclusion criteria were children ≤ 16 years of age, disease-associated NLRP3 mutation, more than 3 self-limiting episodes of fever > 38.5 ° C, and increased inflammation markers. Clinical, epidemiological and genetic data were evaluated via questionnaires.
Findings: 6 out of 14 patients were identified in Clinic-ESPED (n1) and 13 / 14 in Laboratory-ESPED(n2). Clinical and laboratory surveys overlapped in 5 of 14 cases. The incidence of CAPS in German children was estimated to be 3.43 per 10⁷ person-years. The patients carried 11 different NLRP3 mutations and were classified as MWS(n = 6), CINCA (n = 4), FCAS (n = 1) and undefined CAPS (n = 3).
Interpretation: The incidence of CAPS in Germany is very low and corresponds to 2-7 newly diagnosed patients ≤ 16 years per year.
Cracking the NLRP3 code: Pioneering precision medicine for inflammation.
Weber A, Mateo Tortola M, Kuemmerle-Deschner J J Exp Med. 2024; 221(5).
PMID: 38536100 PMC: 10978778. DOI: 10.1084/jem.20240221.
Moltrasio C, Romagnuolo M, Marzano A Front Immunol. 2022; 13:1007705.
PMID: 36275641 PMC: 9583146. DOI: 10.3389/fimmu.2022.1007705.
Welzel T, Kuemmerle-Deschner J J Clin Med. 2021; 10(1).
PMID: 33401496 PMC: 7794776. DOI: 10.3390/jcm10010128.
Samson J, Ravindran Menon D, Vaddi P, Kalani Williams N, Domenico J, Zhai Z Front Immunol. 2020; 11:584364.
PMID: 33329557 PMC: 7711157. DOI: 10.3389/fimmu.2020.584364.
Theodoropoulou K, Wittkowski H, Busso N, Von Scheven-Gete A, Moix I, Vanoni F Front Immunol. 2020; 11:877.
PMID: 32477355 PMC: 7241420. DOI: 10.3389/fimmu.2020.00877.